Masimo Return on Tangible Equity 2010-2024 | MASI
Current and historical return on tangible equity values for Masimo (MASI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Masimo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $-0.31B | $0.66B | -46.55% |
| 2024-09-30 | $0.08B | $0.69B | 12.27% |
| 2024-06-30 | $0.08B | $0.65B | 13.16% |
| 2024-03-31 | $0.08B | $0.62B | 13.66% |
| 2023-12-31 | $0.08B | $0.61B | 14.41% |
| 2023-09-30 | $0.09B | $0.55B | 16.20% |
| 2023-06-30 | $0.12B | $0.56B | 21.96% |
| 2023-03-31 | $0.12B | $0.56B | 23.80% |
| 2022-12-31 | $0.14B | $0.53B | 20.30% |
| 2022-09-30 | $0.17B | $0.47B | 18.40% |
| 2022-06-30 | $0.19B | $0.43B | 16.81% |
| 2022-03-31 | $0.22B | $1.41B | 16.74% |
| 2021-12-31 | $0.23B | $1.41B | 18.06% |
| 2021-09-30 | $0.23B | $1.29B | 18.97% |
| 2021-06-30 | $0.22B | $1.21B | 18.30% |
| 2021-03-31 | $0.23B | $1.15B | 18.81% |
| 2020-12-31 | $0.24B | $1.23B | 19.72% |
| 2020-09-30 | $0.22B | $1.28B | 18.68% |
| 2020-06-30 | $0.22B | $1.21B | 19.57% |
| 2020-03-31 | $0.21B | $1.15B | 19.54% |
| 2019-12-31 | $0.20B | $1.12B | 19.02% |
| 2019-09-30 | $0.19B | $1.06B | 19.38% |
| 2019-06-30 | $0.20B | $0.99B | 21.27% |
| 2019-03-31 | $0.20B | $0.96B | 22.45% |
| 2018-12-31 | $0.19B | $0.92B | 23.72% |
| 2018-09-30 | $0.14B | $0.86B | 18.35% |
| 2018-06-30 | $0.12B | $0.78B | 16.63% |
| 2018-03-31 | $0.12B | $0.72B | 17.48% |
| 2017-12-31 | $0.13B | $0.68B | 19.30% |
| 2017-09-30 | $0.36B | $0.67B | 59.19% |
| 2017-06-30 | $0.35B | $0.66B | 68.82% |
| 2017-03-31 | $0.34B | $0.59B | 82.66% |
| 2016-12-31 | $0.31B | $0.51B | 99.13% |
| 2016-09-30 | $0.11B | $0.28B | 45.08% |
| 2016-06-30 | $0.10B | $0.25B | 44.25% |
| 2016-03-31 | $0.09B | $0.22B | 39.91% |
| 2015-12-31 | $0.08B | $0.23B | 34.55% |
| 2015-09-30 | $0.08B | $0.22B | 32.26% |
| 2015-06-30 | $0.08B | $0.24B | 30.22% |
| 2015-03-31 | $0.07B | $0.28B | 27.33% |
| 2014-12-31 | $0.07B | $0.26B | 27.44% |
| 2014-09-30 | $0.06B | $0.23B | 22.57% |
| 2014-06-30 | $0.06B | $0.27B | 22.34% |
| 2014-03-31 | $0.07B | $0.30B | 23.99% |
| 2013-12-31 | $0.06B | $0.28B | 22.92% |
| 2013-09-30 | $0.06B | $0.26B | 26.64% |
| 2013-06-30 | $0.06B | $0.24B | 25.78% |
| 2013-03-31 | $0.06B | $0.23B | 25.30% |
| 2012-12-31 | $0.06B | $0.23B | 24.56% |
| 2012-09-30 | $0.06B | $0.26B | 23.20% |
| 2012-06-30 | $0.06B | $0.28B | 23.10% |
| 2012-03-31 | $0.06B | $0.26B | 22.90% |
| 2011-12-31 | $0.06B | $0.27B | 23.99% |
| 2011-09-30 | $0.07B | $0.29B | 25.93% |
| 2011-06-30 | $0.07B | $0.27B | 27.66% |
| 2011-03-31 | $0.06B | $0.24B | 27.92% |
| 2010-12-31 | $0.07B | $0.22B | 33.49% |
| 2010-09-30 | $0.07B | $0.24B | 30.47% |
| 2010-06-30 | $0.07B | $0.22B | 28.39% |
| 2010-03-31 | $0.07B | $0.20B | 27.15% |
| 2009-12-31 | $0.05B | $0.28B | 20.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.002B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Nevro (NVRO) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |